{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "16730806", "DateCompleted": {"Year": "2007", "Month": "10", "Day": "15"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2006", "Month": "05", "Day": "15"}], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0166-3542", "JournalIssue": {"Volume": "74", "Issue": "2", "PubDate": {"Year": "2007", "Month": "May"}}, "Title": "Antiviral research", "ISOAbbreviation": "Antiviral Res"}, "ArticleTitle": "Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction.", "Pagination": {"StartPage": "92", "EndPage": "101", "MedlinePgn": "92-101"}, "Abstract": {"AbstractText": ["Severe acute respiratory syndrome (SARS) is an emerging infectious disease caused by a novel coronavirus (SARS-CoV). SARS-CoV spike (S) protein, a type I membrane-bound protein, is essential for the viral attachment to the host cell receptor angiotensin-converting enzyme 2 (ACE2). By screening 312 controlled Chinese medicinal herbs supervised by Committee on Chinese Medicine and Pharmacy at Taiwan, we identified that three widely used Chinese medicinal herbs of the family Polygonaceae inhibited the interaction of SARS-CoV S protein and ACE2. The IC(50) values for Radix et Rhizoma Rhei (the root tubers of Rheum officinale Baill.), Radix Polygoni multiflori (the root tubers of Polygonum multiflorum Thunb.), and Caulis Polygoni multiflori (the vines of P. multiflorum Thunb.) ranged from 1 to 10 microg/ml. Emodin, an anthraquinone compound derived from genus Rheum and Polygonum, significantly blocked the S protein and ACE2 interaction in a dose-dependent manner. It also inhibited the infectivity of S protein-pseudotyped retrovirus to Vero E6 cells. These findings suggested that emodin may be considered as a potential lead therapeutic agent in the treatment of SARS."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular Biology Laboratory, Graduate Institute of Chinese Medical Science, China Medical University, Taichung, Taiwan."}], "Identifier": [], "LastName": "Ho", "ForeName": "Tin-Yun", "Initials": "TY"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wu", "ForeName": "Shih-Lu", "Initials": "SL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Chen", "ForeName": "Jaw-Chyun", "Initials": "JC"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Li", "ForeName": "Chia-Cheng", "Initials": "CC"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Hsiang", "ForeName": "Chien-Yun", "Initials": "CY"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Antiviral Res", "NlmUniqueID": "8109699", "ISSNLinking": "0166-3542"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Angiotensin-Converting Enzyme Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "0", "NameOfSubstance": "Membrane Glycoproteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Spike Glycoprotein, Coronavirus"}, {"RegistryNumber": "0", "NameOfSubstance": "Viral Envelope Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "spike glycoprotein, SARS-CoV"}, {"RegistryNumber": "0", "NameOfSubstance": "spike protein, mouse hepatitis virus"}, {"RegistryNumber": "EC 3.4.15.1", "NameOfSubstance": "Peptidyl-Dipeptidase A"}, {"RegistryNumber": "EC 3.4.17.23", "NameOfSubstance": "Angiotensin-Converting Enzyme 2"}, {"RegistryNumber": "KA46RNI6HN", "NameOfSubstance": "Emodin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Angiotensin-Converting Enzyme 2"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Angiotensin-Converting Enzyme Inhibitors"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "Chlorocebus aethiops"}, {"QualifierName": ["drug effects"], "DescriptorName": "Coronavirus"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Emodin"}, {"QualifierName": ["metabolism"], "DescriptorName": "Membrane Glycoproteins"}, {"QualifierName": ["metabolism"], "DescriptorName": "Peptidyl-Dipeptidase A"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemistry"], "DescriptorName": "Polygonum"}, {"QualifierName": ["drug effects"], "DescriptorName": "Retroviridae"}, {"QualifierName": ["chemistry"], "DescriptorName": "Rheum"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Severe acute respiratory syndrome-related coronavirus"}, {"QualifierName": [], "DescriptorName": "Spike Glycoprotein, Coronavirus"}, {"QualifierName": [], "DescriptorName": "Vero Cells"}, {"QualifierName": ["metabolism"], "DescriptorName": "Viral Envelope Proteins"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Agarwal S.K., Singh S.S., Verma S., Kumar S. Antifungal activity of anthraquinone derivatives from Rheum emodi. J. Ethnopharmacol. 2000;72:43\u201346.", "ArticleIdList": ["10967452"]}, {"Citation": "Alves D.S., Pe\u2032rez-Fons L., Estepa A., Micol V. Membrane-related effects underlying the biological activity of the anthraquinones emodin and barbaloin. Biochem. Pharmacol. 2004;68:549\u2013561.", "ArticleIdList": ["15242821"]}, {"Citation": "Arosio B., Gagliano N., Fusaro L.M., Parmeggiani L., Tagliabue J., Galetti P., DeCastri D., Moscheni C., Annoni G. Aloe-Emodin quinone pretreatment reduces acute liver injury induced by carbon tetrachloride. Pharmacol. Toxicol. 2000;87:229\u2013233.", "ArticleIdList": ["11129503"]}, {"Citation": "Barnard D.L., Huffman J.H., Morris J.L.B., Wood S.G., Hughes B.G., Sidwell R.W. Evaluation of the antiviral activity of anthraquinones, anthrones and anthraquinone derivatives against human cytomegalovirus. Antiviral Res. 1992;17:63\u201377.", "ArticleIdList": ["1310583"]}, {"Citation": "Battistutta R., Sarno S., DeMoliner E., Papinutto E., Zanotti G., Pinna L.A. The replacement of ATP by the competitive inhibitor emodin induces conformational modifications in the catalytic site of protein kinase CK2. J. Biol. Chem. 2000;275:29618\u201329622.", "ArticleIdList": ["10882732"]}, {"Citation": "Bosch B.J., van der Zee R., de Haan C.A., Rottier P.J. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J. Virol. 2003;77:8801\u20138811.", "ArticleIdList": ["PMC167208", "12885899"]}, {"Citation": "Chan K.S., Lai S.T., Chu C.M., Tsui E., Tam C.Y., Wong M.M., Tse M.W., Que T.L., Peiris J.S., Sung J., Wong V.C., Yuen K.Y. Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study. Hong Kong Med. J. 2003;9:399\u2013406.", "ArticleIdList": ["14660806"]}, {"Citation": "Chen F., Chan K.H., Jiang Y., Kao R.Y., Lu H.T., Fan K.W., Cheng V.C., Tsui W.H., Hung I.F., Lee T.S., Guan Y., Peiris J.S., Yuen K.Y. In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. J. Clin. Virol. 2004;31:69\u201375.", "ArticleIdList": ["PMC7128415", "15288617"]}, {"Citation": "Chen Y.C., Shen S.C., Lee W.R., Hsu F.L., Lin H.Y., Ko C.H., Tseng S.W. Emodin induces apoptosis in human promyeloleukemic HL-60 cells accompanied by activation of caspase 3 cascade but independent of reactive oxygen species production. Biochem. Pharmacol. 2002;64:1713\u20131724.", "ArticleIdList": ["12445860"]}, {"Citation": "Chen Z., Zhang L., Qin C., Ba L., Yi C.E., Zhang F., Wei Q., He T., Yu W., Yu J., Gao H., Tu X., Gettie A., Farzan M., Yuen K.Y., Ho D.D. Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region. J. Virol. 2005;79:2678\u20132688.", "ArticleIdList": ["PMC548443", "15708987"]}, {"Citation": "Cinatle J., Jr., Michaelis M., Hoever G., Preiser W., Doerr H.W. Development of antiviral therapy for severe acute respiratory syndrome. Antiviral Res. 2005;66:81\u201397.", "ArticleIdList": ["PMC7132397", "15878786"]}, {"Citation": "Cinatl J., Jr., Morgenstern B., Bauer G., Chandra P., Rabenau H., Doerr H.W. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet. 2003;361:2045\u20132046.", "ArticleIdList": ["PMC7112442", "12814717"]}, {"Citation": "Cinatl J., Jr., Morgenstern B., Bauer G., Chandra P., Rabenau H., Doerr H.W. Treatment of SARS with human interferons. Lancet. 2003;362:293\u2013294.", "ArticleIdList": ["PMC7112413", "12892961"]}, {"Citation": "Drosten C., Gunther S., Preiser W., van der Werf S., Brodt H.R., Becker S., Rabenau H., Panning M., Kolesnikova L., Fouchier R.A., Berger A., Burguiere A.M., Cinatl J., Eickmann M., Escriou N., Grywna K., Kramme S., Manuguerra J.C., Muller S., Rickerts V., Sturmer M., Vieth S., Klenk H.D., Osterhaus A.D., Schmitz H., Doerr H.W. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 2003;348:1967\u20131976.", "ArticleIdList": ["12690091"]}, {"Citation": "Fouchier R.A., Kuiken T., Schutten M., van Amerongen G., van Doornum G.J.J., van den Hoogen B.G., Peiris M., Lim W., Stohr K., Osterhaus A.D.M.E. Koch's postulates fulfilled for SARS virus. Nature. 2003;423:240.", "ArticleIdList": ["PMC7095368", "12748632"]}, {"Citation": "Greenough T.C., Babcock G.J., Roberts A., Hernandez H.J., Thomas W.D., Coccia J.A., Graziano R.F., Srinivasan M., Lowy I., Finberg R.W., Subbarao K., Vogel L., Somasundaran M., Luzuriaga K., Sullivan J.L., Ambrosino D.M. Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice. J. Infect. Dis. 2005;191:507\u2013514.", "ArticleIdList": ["PMC7110081", "15655773"]}, {"Citation": "Guerra B., Issinger O.G. Protein kinase CK2 and its role in cellular proliferation, development and pathology. Electrophoresis. 1999;20:391\u2013408.", "ArticleIdList": ["10197447"]}, {"Citation": "Ho T.Y., Wu S.L., Chen J.C., Wei Y.C., Cheng S.E., Chang Y.H., Liu H.J., Hsiang C.Y. Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction. Antiviral Res. 2006;69:70\u201376.", "ArticleIdList": ["PMC7114127", "16337697"]}, {"Citation": "Ho T.Y., Wu S.L., Cheng S.E., Wei Y.C., Huang S.P., Hsiang C.Y. Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein. Biochem. Biophys. Res. Commun. 2004;313:938\u2013947.", "ArticleIdList": ["PMC7111049", "14706633"]}, {"Citation": "Hofmann H., Hattermann K., Marzi A., Gramberg T., Geiner M., Krumbiegel M., Kuate S., Uberla K., Niedrig M., Pohlmann S.H. S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients. J. Virol. 2004;78:6134\u20136142.", "ArticleIdList": ["PMC416513", "15163706"]}, {"Citation": "Hofmann H., Geier M., Marzi A., Krumbiegel M., Peipp M., Fey G.H., Gramberg T., Pohlmann S. Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor. Biochem. Biophys. Res. Commun. 2004;319:1216\u20131221.", "ArticleIdList": ["PMC7111153", "15194496"]}, {"Citation": "Hsiang C.Y., Hsieh C.L., Wu S.L., Lai I.L., Ho T.Y. Inhibitory effect of anti-pyretic and anti-inflammatory herbs on herpes simplex virus replication. Am. J. Chin. Med. 2001;29:459\u2013467.", "ArticleIdList": ["11789588"]}, {"Citation": "Hsiang C.Y., Wu S.L., Ho T.Y. Morin inhibited 12-O-tetradecanoylphorbol-13-acetate-induced hepatocellular transformation via activator protein 1 signaling pathway and cell cycle progression. Biochem. Pharmacol. 2005;69:1603\u20131611.", "ArticleIdList": ["15896340"]}, {"Citation": "Huang H.C., Chu S.H., Chao P.D. Vasorelaxants from Chinese herbs, emodin and scoparone, possess immunosuppressive properties. Eur. J. Pharmacol. 1991;198:211\u2013213.", "ArticleIdList": ["1830846"]}, {"Citation": "Konoshima T., Kozuka M., Koyama J., Okatani T., Tagahara K. Studies on inhibitors of skin tumor promotion. VI. Inhibitory effects of quinones on Epstein-Barr virus activation. J. Nat. Prod. 1989;52:987\u2013995.", "ArticleIdList": ["2558164"]}, {"Citation": "Koyama J., Morita I., Kawanishi K., Tagahara K., Kobayashi N. Capillary electrophoresis for simultaneous determination of emodin, chrysophanol, and their 8-beta-d-glucosides. Chem. Pharm. Bull. (Tokyo) 2003;51:418\u2013420.", "ArticleIdList": ["12672996"]}, {"Citation": "Koyama M., Kelly T.R., Watanabe K.A. Novel type of potential anticancer agents derived from chrysophanol and emodin. Some structure\u2013activity relationship studies. J. Med. Chem. 1988;31:283\u2013284.", "ArticleIdList": ["3339601"]}, {"Citation": "Ksiazek T.G., Erdman D., Goldsmith C.S., Zaki S.R., Peret T., Emery S., Tong S., Comer J.A., Lim W., Rollin P.E., Dowell S.F., Ling A., Humphrey C.D., Shieh W., Guarner J., Paddock C.D., Rota P., Fields B., DeRisi J., Yang J., Cox N., Hughes J.M., LeDuc J.W., Bellini W.J., Anderson L.J. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 2003;348:1953\u20131966.", "ArticleIdList": ["12690092"]}, {"Citation": "Kumar A., Dhawan S., Aggarwal B.B. Emodin (3-methyl-1,6,8-trihydroxyanthraquinone) inhibits TNF-induced NF-\u03baB activation, I\u03baB degradation, and expression of cell surface adhesion proteins in human vascular endothelial cells. Oncogene. 1998;17:913\u2013918.", "ArticleIdList": ["9780008"]}, {"Citation": "Li W., Moore M.J., Vasilieva N., Sui J., Wong S.K., Berne M.A., Somasundaran M., Sullivan J.L., Luzuriaga K., Greenough T.C., Choe H., Farzan M. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450\u2013454.", "ArticleIdList": ["PMC7095016", "14647384"]}, {"Citation": "Lin C.W., Tsai F.J., Tsai C.H., Lai C.C., Wan L., Ho T.Y., Hsieh C.C., Chao P.D. Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. Antiviral Res. 2005;68:36\u201342.", "ArticleIdList": ["PMC7114321", "16115693"]}, {"Citation": "Marra M.A., Jones S.J., Astell C.R., Holt R.A., Brooks-Wilson A., Butterfield Y.S., Khattra J., Asano J.K., Barber S.A., Chan S.Y., Cloutier A., Coughlin S.M., Freeman D., Girn N., Griffith O.L., Leach S.R., Mayo M., McDonald H., Montgomery S.B., Pandoh P.K., Petrescu A.S., Robertson A.G., Schein J.E., Siddiqui A., Smailus D.E., Stott J.M., Yang G.S., Plummer F., Andonov A., Artsob H., Bastien N., Bernard K., Booth T.F., Bowness D., Czub M., Drebot M., Fernando L., Flick R., Garbutt M., Gray M., Grolla A., Jones S., Feldmann H., Meyers A., Kabani A., Li Y., Normand S., Stroher U., Tipples G.A., Tyler S., Vogrig R., Ward D., Watson B., Brunham R.C., Krajden M., Petric M., Skowronski D.M., Upton C., Roper R.L. The Genome sequence of the SARS-associated coronavirus. Science. 2003;300:1399\u20131404.", "ArticleIdList": ["12730501"]}, {"Citation": "Moore M.J., Dorfman T., Li W., Wong S.K., Li Y., Kuhn J.H., Coderre J., Vasilieva N., Han Z., Greenough T.C., Farzan M., Choe H. Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2. J. Virol. 2004;78:10628\u201310635.", "ArticleIdList": ["PMC516384", "15367630"]}, {"Citation": "Nonaka G., Minami M., Nishioka I. Studies on rhubarb (Rhei rhizoma). III. Stilbene glycosides. Chem. Pharm. Bull. (Tokyo) 1977;25:2300\u20132305.", "ArticleIdList": ["589726"]}, {"Citation": "Peiris J.S.M., Lai S.T., Poon L.L.M., Guan Y., Yam L.Y.C., Lim W., Nicholls J., Yee W.K.S., Yan W.W., Cheung M.T., Cheng V.C.C., Chan K.H., Tsang D.N.S., Yung R.W.H., Ng T.K., Yuen K.Y., Members of the SARS Study Group Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 2003;361:1319\u20131325.", "ArticleIdList": ["PMC7112372", "12711465"]}, {"Citation": "Petit C.M., Melancon J.M., Chouljenko V.N., Colgrove R., Farzan M., Knipe D.M., Kousoulas K.G. Genetic analysis of the SARS-coronavirus spike glycoprotein functional domains involved in cell-surface expression and cell-to-cell fusion. Virology. 2005;341:215\u2013230.", "ArticleIdList": ["PMC7111838", "16099010"]}, {"Citation": "Rota P.A., Oberste M.S., Monroe S.S., Nix W.A., Campagnoli R., Icenogle J.P., Penaranda S., Bankamp B., Maher K., Chen M.H., Tong S., Tamin A., Lowe L., Frace M., DeRisi J.L., Chen Q., Wang D., Erdman D.D., Peret T.C., Burns C., Ksiazek T.G., Rollin P.E., Sanchez A., Liffick S., Holloway B., Limor J., McCaustland K., Olsen-Rasmussen M., Fouchier R., Gunther S., Osterhaus A.D., Drosten C., Pallansch M.A., Anderson L.J., Bellini W.J. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science. 2003;300:1394\u20131399.", "ArticleIdList": ["12730500"]}, {"Citation": "Schinazi R.F., Chu C.K., Babu J.R., Oswald B.J., Saalmann V., Cannon D.L., Eriksson B.F.H., Nasr M. Anthraquinones as a new class of antiviral agents against human immunodeficiency virus. Antiviral Res. 1990;13:265\u2013272.", "ArticleIdList": ["1697740"]}, {"Citation": "Simmons G., Reeves J.D., Rennekamp A.J., Amberg S.M., Piefer A.J., Bates P. Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc. Natl. Acad. Sci. U.S.A. 2004;101:4240\u20134245.", "ArticleIdList": ["PMC384725", "15010527"]}, {"Citation": "Sui J., Li W., Murakami A., Tamin A., Matthews L.J., Wong S.K., Moore M.J., Tallarico A.S., Olurinde M., Choe H., Anderson L.J., Bellini W.J., Farzan M., Marasco W.A. Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proc. Natl. Acad. Sci. U.S.A. 2004;101:2536\u20132541.", "ArticleIdList": ["PMC356985", "14983044"]}, {"Citation": "Sui J., Li W., Roberts A., Matthews L.J., Murakami A., Vogel L., Wong S.K., Subbarao K., Farzan M., Marasco W.A. Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants. J. Virol. 2005;79:5900\u20135906.", "ArticleIdList": ["PMC1091676", "15857975"]}, {"Citation": "Sydiskis R.J., Owen D.G., Lohr J.L., Rosler K.H.A., Blomster R.N. Inactivation of enveloped viruses by anthraquinones extracted from plants. Antimicrob. Agents Chemother. 1991;35:2463\u20132466.", "ArticleIdList": ["PMC245413", "1810179"]}, {"Citation": "Tan E.L., Ooi E.E., Lin C.Y., Tan H.C., Ling A.E., Lim B., Stanton L.W. Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs. Emerg. Infect. Dis. 2004;10:581\u2013586.", "ArticleIdList": ["PMC3323075", "15200845"]}, {"Citation": "Tan Y.J., Lim S.G., Hong W. Characterization of viral proteins encoded by the SARS-coronavirus genome. Antiviral Res. 2005;65:69\u201378.", "ArticleIdList": ["PMC7114173", "15708633"]}, {"Citation": "Tripet B., Howard M.W., Jobling M., Holmes R.K., Holmes K.V., Hodges R.S. Structural characterization of the SARS-coronavirus spike S fusion protein core. J. Biol. Chem. 2004;279:20836\u201320849.", "ArticleIdList": ["PMC8060857", "14996844"]}, {"Citation": "Wu C.J., Jan J.T., Chen C.M., Hsieh H.P., Hwang D.R., Liu H.W., Liu C.Y., Huang H.W., Chen S.C., Hong C.F., Lin R.K., Chao Y.S., Hsu J.T. Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide. Antimicrob. Agents Chemother. 2004;48:2693\u20132696.", "ArticleIdList": ["PMC434198", "15215127"]}, {"Citation": "Wu C.Y., Jan J.T., Ma S.H., Kuo C.J., Juan H.F., Cheng Y.S., Hsu H.H., Huang H.C., Wu D., Brik A., Liang F.S., Liu R.S., Fang J.M., Chen S.T., Liang P.H., Wong C.H. Small molecules targeting severe acute respiratory syndrome human coronavirus. Proc. Natl. Acad. Sci. U.S.A. 2004;101:10012\u201310017.", "ArticleIdList": ["PMC454157", "15226499"]}, {"Citation": "Xiao P.G., Xing S.T., Wang L.W. Immunological aspects of Chinese medicinal plants as antiageing drugs. J. Ethnopharmacol. 1993;38:167\u2013175.", "ArticleIdList": ["8510465"]}, {"Citation": "Yang Z.Y., Kong W.P., Huang Y., Roberts A., Murphy B.R., Subbarao K., Nabel G.J. A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature. 2004;428:561\u2013564.", "ArticleIdList": ["PMC7095382", "15024391"]}, {"Citation": "Yi C.E., Ba L., Zhang L., Ho D.D., Chen Z. Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain. J. Virol. 2005;79:11638\u201311646.", "ArticleIdList": ["PMC1212612", "16140741"]}, {"Citation": "Yi L., Li Z., Yuan K., Qu X., Chen J., Wang G., Zhang H., Luo H., Zhu L., Jiang P., Chen L., Shen Y., Luo M., Zuo G., Hu J., Duan D., Nie Y., Shi X., Wang W., Han Y., Li T., Liu Y., Ding M., Deng H., Xu X. Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells. J. Virol. 2004;78:11334\u201311339.", "ArticleIdList": ["PMC521800", "15452254"]}, {"Citation": "Zhang M.M., Liu X.M., He L. Effect of integrated traditional Chinese and Western medicine on SARS: a review of clinical evidence. World J. Gastroenterol. 2004;10:3500\u20133505.", "ArticleIdList": ["PMC4576235", "15526373"]}, {"Citation": "Zhang X.W., Yap Y.L. Old drugs as lead compounds for a new disease? Binding analysis of SARS coronavirus main proteinase with HIV, psychotic and parasite drugs. Bioorg. Med. Chem. 2004;12:2517\u20132521.", "ArticleIdList": ["PMC7126105", "15110833"]}, {"Citation": "Zhou X.M., Chen Q.H. Biochemical study of Chinese rhubarb. XXII. Inhibitory effect of anthraquinone derivatives on Na+-K+-ATPase of the rabbit renal medulla and their diuretic action. Acta Pharmacol. Sin. 1988;23:17\u201320.", "ArticleIdList": ["2840798"]}]}], "History": [{"Year": "2006", "Month": "1", "Day": "9"}, {"Year": "2006", "Month": "4", "Day": "10"}, {"Year": "2006", "Month": "4", "Day": "11"}, {"Year": "2006", "Month": "5", "Day": "30", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "10", "Day": "16", "Hour": "9", "Minute": "0"}, {"Year": "2006", "Month": "5", "Day": "30", "Hour": "9", "Minute": "0"}, {"Year": "2006", "Month": "5", "Day": "15"}], "PublicationStatus": "ppublish", "ArticleIdList": ["16730806", "PMC7114332", "10.1016/j.antiviral.2006.04.014", "S0166-3542(06)00121-5"]}}], "PubmedBookArticle": []}